Gritstone bio announced that the company’s Board of Directors granted seven employees nonqualified stock options to purchase an aggregate of 35,100 shares of its common stock with an exercise price of $2.24, which is equal to the closing price of Gritstone’s common stock on October 11, 2022, the date of the grant. These stock options are part of an inducement material to each of the new employees becoming an employee of Gritstone, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options will vest over a four-year period, with 25% of the options vesting on the first anniversary of the employees’ date of hire, and 1/48th of the options vesting monthly thereafter, subject to the employees’ continued employment with Gritstone on such vesting dates.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GRTS:
- Lyell Immunopharma names Rahsaan Thompson as chief legal officer
- Gritstone announces inducement grants under Nasdaq listing rule
- Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Gritstone presents initial Phase 2 data from its SLATE program
- Gritstone Presents Positive Initial Phase 2 Data in Late-Line Solid Tumor Patients Treated With KRAS-Directed Immunotherapy (SLATE) at ESMO 2022